Shengguang Zhao (Wei-Xiang Qi)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Neoadjuvant Chemotherapy

Locally Advanced

Top Venues

Journal of oncology

Cancer immunology, immunotherapy : CII

Thoracic cancer

International journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Chu-Ying Chen, Si-Yue Zheng, Gang Cai, Cheng Xu, Rong Cai, Min Li, Kun-Wei Shen, Xiao-Song Chen, Dan Ou, Shengguang Zhao, Lu Cao, Jia-Yi Chen
Postoperative Radiotherapy Contributes to the Survival Benefit of Breast-Conserving Therapy over Mastectomy. Journal of oncology 2022 (2022)
Chu-Ying Chen, Si-Yue Zheng, Gang Cai, Cheng Xu, Rong Cai, Min Li, Kun-Wei Shen, Xiao-Song Chen, Dan Ou, Shengguang Zhao, Lu Cao, Jia-Yi Chen
Postoperative Radiotherapy Contributes to the Survival Benefit of Breast-Conserving Therapy over Mastectomy. Journal of oncology 2022 (2022)
Wei-Xiang Qi, Yi Xiang, Shengguang Zhao, Jiayi Chen
Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab. Cancer immunology, immunotherapy : CII 70 (11) (2021)
Wei-Xiang Qi, Siyue Zheng, Lu Cao, Cheng Xu, Shengguang Zhao, Jiayi Chen
Simultaneous integrated boost for mediastinal lymph node recurrence after radical surgery for esophageal cancer: Interim results from a phase I/II prospective study. Thoracic cancer 12 (8) (2021)
Wei-Xiang Qi, Chunrong Chen, Shengguang Zhao, Jiayi Chen
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of locally advanced esophageal cancer: a population-based analysis. International journal of clinical oncology (2021)